Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee advances bill to ban concentrated 7‑hydroxymitragynine while keeping narrow trace allowances in kratom products
Summary
The Senate Business and Labor Committee voted to recommend S.B. 48, which would schedule 7‑hydroxymitragynine as a Schedule I substance with a narrowly defined trace‑amount exception intended to exempt naturally occurring small amounts in kratom leaf while targeting synthesized concentrates linked to overdoses.
Sen. Vickers, sponsor of S.B. 48, told the Senate Business and Labor Committee on Jan. 21 that the bill would reschedule 7‑hydroxymitragynine (7‑OH) "as a schedule 1" while carving out a narrow exception for trace natural amounts in kratom products. The sponsor said the proposal sets the trace threshold at 0.4% of the total kratom alkaloid composition to distinguish naturally occurring levels from concentrated, semi‑synthetic products. "If you have someone that has overdosed on it, you can give naloxone and they respond," Sen. Vickers said, citing the opioid‑like effects of concentrated 7‑OH.
The proposal…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
